As lymph node metastasis is well known to be strongly associated with prognosis of breast cancers (Colpaert et al, 2001), assessment of the phosphorylation status of JNK or FADD might provide relevant information for the efficacy of clinical therapy. This evidence concerns the gene FADD and breast carcinoma.